Home/Rare Diseases/Rocky Mountain Spotted Fever

Tick-Borne & Infectious

Rocky Mountain Spotted Fever (RMSF) Clinical Trials

Also called RMSF, Spotted fever rickettsiosis, Rickettsia rickettsii infection, Rickettsia parkeri rickettsiosis, Pacific Coast tick fever

Rocky Mountain spotted fever is caused by Rickettsia rickettsii, a bacterium that infects the cells lining small blood vessels. It spreads through the bite of the American dog tick east of the Rockies, the Rocky Mountain wood tick in the mountain states, and the brown dog tick in parts of the Southwest.

View 0 active trialsMatch me to a trial

About Rocky Mountain Spotted Fever

Rocky Mountain spotted fever is caused by Rickettsia rickettsii, a bacterium that infects the cells lining small blood vessels. It spreads through the bite of the American dog tick east of the Rockies, the Rocky Mountain wood tick in the mountain states, and the brown dog tick in parts of the Southwest. It is the most severe of a family of related infections called spotted fever rickettsioses. The milder members include Rickettsia parkeri rickettsiosis, spread by the Gulf Coast tick in the Southeast, and Pacific Coast tick fever in California, Oregon and Washington. Those usually start with a dark scab, or eschar, at the bite, which is rare in Rocky Mountain spotted fever itself. Because antibody tests cannot tell these apart, the CDC counts them together.

The danger is speed. The rash that gives the disease its name appears in 9 of 10 patients eventually, but in fewer than half during the first 3 days, so doctors cannot wait for it. The CDC says doxycycline is the treatment for people of all ages, including children under 8 and pregnant women, that it works best in the first 5 days of illness, and that using any other antibiotic is linked to a higher risk of death. Short courses have not stained children's permanent teeth. Treatment should start on suspicion, before test results come back.

Diagnosis is confirmed afterward with antibody tests on 2 blood samples taken weeks apart, or by PCR on blood or a skin biopsy, though a negative PCR does not rule it out. Survivors of severe disease can be left with amputations, hearing loss or lasting mental changes. There is no vaccine, and antibiotics are not recommended to prevent infection after a bite.

Common Symptoms of Rocky Mountain Spotted Fever

Recognizing the signs of Rocky Mountain Spotted Fever early can lead to faster diagnosis and better outcomes. Symptoms may vary in severity from person to person. If you or a loved one are experiencing any of the following, consider speaking with a specialist.

  • Sudden fever and severe headache, 3 to 12 days after a tick bite
  • Nausea, vomiting, stomach pain and muscle pain
  • A rash that usually appears 2 to 4 days after the fever starts, often beginning on wrists and ankles
  • Swelling around the eyes and on the backs of the hands
  • Confusion, breathing trouble or kidney failure in severe cases
  • A dark scab at the bite site in the milder related infections, which is uncommon in Rocky Mountain spotted fever

Who Rocky Mountain Spotted Fever Affects

Anyone bitten by an infected American dog tick, Rocky Mountain wood tick or brown dog tick. Severe disease is most likely in children under 10, people with G6PD deficiency, and anyone whose treatment starts late. In Arizona and northern Mexico the brown dog tick spreads it around homes year-round, with unusually high death rates, especially among children.

Find Your Next Step

Answer a few questions and we'll point you to the right tools and information for where you are right now.

Where are you in your Rocky Mountain Spotted Fever journey?

FDA-Approved Treatments for Rocky Mountain Spotted Fever

There is currently 1 FDA-approved medication for Rocky Mountain Spotted Fever. These therapies represent the current standard of care and may be used alongside or compared against investigational treatments in active clinical trials.

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

Ask about these treatments
Answers with sources, in plain English
Start withor ask

Help Paying for Rocky Mountain Spotted Fever Treatment

Charity funds and drugmaker programs for Rocky Mountain Spotted Fever, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Open the full patient assistance finder →

Side Effect Explorer

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Questions about side effects?
I can help you understand what these reports mean
Start withor ask

Diagnosis and Testing

Tick-borne Rickettsia rickettsii infection, diagnosed by paired antibody tests or PCR; not genetic.

Trusted Rocky Mountain Spotted Fever Resources

Reputable organizations and medical references for learning more about Rocky Mountain Spotted Fever, including disease registries, foundation resources, and clinical guidelines.

Active Clinical Trials for Rocky Mountain Spotted Fever

This Rocky Mountain Spotted Fever clinical trial finder lists studies as they become available, with eligibility criteria in plain English. These studies play a critical role in advancing care for tick-borne & infectious conditions and may offer access to treatments not yet widely available. Each trial below is sourced directly from ClinicalTrials.gov, with eligibility criteria translated into plain English to help patients and caregivers evaluate whether a study may be a fit.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

No active clinical trials yet

Rocky Mountain Spotted Fever is a classified rare disease, but clinical trial activity for it is limited. That's part of why we track it. When a trial opens, Trial Friend will have it.

Get notified the moment a Rocky Mountain Spotted Fever trial is registered on ClinicalTrials.gov.

Get Rocky Mountain Spotted Fever alerts by email

One email when something new happens for Rocky Mountain Spotted Fever, never a newsletter.

You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Rocky Mountain Spotted Fever. Turn any of these off from the link in every email.

We never share your email. Unsubscribe anytime. Privacy policy

Patient Communities

Connect with other Rocky Mountain Spotted Fever patients, caregivers, and advocacy groups across Facebook groups, Reddit communities, and YouTube channels. These patient communities offer peer support, shared experiences, caregiver resources, and real-time discussion about Rocky Mountain Spotted Fever treatments, clinical trial participation, and day-to-day disease management.

Find the right community
Answers with sources, in plain English
Start withor ask

Related Tick-Borne & Infectious Conditions

Other rare diseases in the tick-borne & infectious category. Patients with Rocky Mountain Spotted Fever may find relevant research, shared treatment pathways, or overlapping clinical trials among these related conditions.

Frequently Asked Questions About Rocky Mountain Spotted Fever